Inventor · disambiguated record
Joseph D. Mosca
Also filed as: MOSCA JOSEPH · MOSCA JOSEPH D
11 granted patents·12 pending applications·1,413 citations·filing 1998–2011
94Inventor score
Top patents by PatentIndex Score
23 records- 0198US6355239B1Uses for non-autologous mesenchymal stem cellsOSIRIS THERAPEUTICS INC·Filed 1999·Granted Mar 12, 2002·441 cites·12 claims
- 0297US7029666B2Uses for non-autologous mesenchymal stem cellsOSIRIS THERAPEUTICS INC·Filed 2002·Granted Apr 18, 2006·164 cites·10 claims
- 0397US6875430B2Mesenchymal stem cells for prevention and treatment of immune responses in transplantationOSIRIS THERAPEUTICS INC·Filed 2001·Granted Apr 5, 2005·160 cites·20 claims
- 0496US6328960B1Mesenchymal stem cells for prevention and treatment of immune responses in transplantationOSIRIS THERAPEUTICS INC·Filed 1999·Granted Dec 11, 2001·242 cites·22 claims
- 0594US6368636B1Mesenchymal stem cells for prevention and treatment of immune responses in transplantationOSIRIS THERAPEUTICS INC·Filed 1999·Granted Apr 9, 2002·153 cites·25 claims
- 0691US6797269B2Mesenchymal stem cells as immunosuppressantsOSIRIS THERAPEUTICS INC·Filed 1999·Granted Sep 28, 2004·122 cites·16 claims
- 0785US7101704B1Antigen presenting mesenchymal stem cellsOSIRIS THERAPEUTICS INC·Filed 2000·Granted Sep 5, 2006·20 cites·18 claims
- 0884US6149906AAntigen presenting cells of the adipocyte lineageOSIRIS THERAPEUTICS INC·Filed 1998·Granted Nov 21, 2000·61 cites·1 claims
- 0975US7579007B2Production of “biological carriers” for induction of immune responses and inhibition of viral replicationJDM TECHNOLOGIES INC·Filed 2002·Granted Aug 25, 2009·6 cites·16 claims
- 1075US7491388B1Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantationOSIRIS THERAPEUTICS INC·Filed 1999·Granted Feb 17, 2009·44 cites·2 claims
- 1171US2010015597A1Production of biological carriers for induction of immune response and inhibition of viral replicationMOSCA JOSEPH D·Filed 2009·Application pending·0 cites
- 1263US2010255111A1Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem CellsOSIRIS THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1361US2009257989A1Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem CellsVANGURI PADMAVATHY·Filed 2009·Application pending·0 cites
- 1460US2009238802A1Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem CellsVANGURI PADMAVATHY·Filed 2009·Application pending·0 cites
- 1556US2007166316A1Tumor-derived biological antigen presenting particlesMOSCA JOSEPH D·Filed 2004·Application pending·0 cites
- 1655US7662608B2Chronic pathogen-expressing cell linesJDM TECHNOLOGIES INC·Filed 2002·Granted Feb 16, 2010·0 cites·17 claims
- 1751US2005175588A1Production of a protein delivery system for in vivo therapeutic treatmentFiled 2003·Application pending·0 cites
- 1849US2011027241A1Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem CellsVANGURI PADMAVATHY·Filed 2010·Application pending·0 cites
- 1949US2011027237A1Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem CellsVANGURI PADMAVATHY·Filed 2010·Application pending·0 cites
- 2049US2004033217A1Intraperitoneal delivery of genetically engineered mesenchymal stem cellsFiled 2003·Application pending·0 cites
- 2148US2004137426A1Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cellsFiled 2003·Application pending·0 cites
- 2245US2010178302A1Chronic pathogen-expressing cell linesJDM TECHNOLOGIES INC·Filed 2010·Application pending·0 cites
- 2345US2011262389A1Tumor-derived Biological Antigen Presenting ParticlesMOSCA JOSEPH D·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →